Digital Cutaneous Vascular Responses to Histamine and Neuropeptides in Raynaud's Phenomenon
- 1 March 1991
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 96 (3), 314-317
- https://doi.org/10.1111/1523-1747.ep12465175
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Calcitonin gene-related peptide and Raynaud's phenomenonThe Lancet, 1990
- SELECTIVE SUPRASENSITIVITY TO CALCITONIN-GENE-RELATED PEPTIDE IN THE HANDS IN RAYNAUD'S PHENOMENONThe Lancet, 1989
- Calcitonin-gene-related-peptide in the treatment of severe Raynaud's phenomenonBritish Journal of Dermatology, 1989
- Substance P regulates the vasodilator activity of calcitonin gene-related peptideNature, 1988
- Systemic scleroderma: Clinical and pathophysiologic aspectsJournal of the American Academy of Dermatology, 1988
- Some effects of calcitonin gene-related peptide in human skin and on histamine releaseBritish Journal of Dermatology, 1986
- Sir Thomas Lewis's nocifensor system, histamine and substance-P-containing primary afferent nervesTrends in Neurosciences, 1983
- ON THE NATURE OF RAYNAUD'S PHENOMENON: THE ROLE OF HISTAMINEThe Lancet, 1983
- AUTONOMIC NEUROEFFECTOR JUNCTIONS—REFLEX VASODILATATION OF THE SKINJournal of Investigative Dermatology, 1977
- RAYNAUDʼS DISEASEThe American Journal of the Medical Sciences, 1932